Efficacy of tocilizumab in patients with severe COVID-19: Survival and clinical outcomes

• Main Authors: Abeer Al-Baadani (Author), Nazik Eltayeb (Author), Eid Alsufyani (Author), Salma Albahrani (Author), Shareefah Basheri (Author), Hawra Albayat (Author), Enas Batubara (Author), Sulafa Ballool (Author), Ayed Al Assiri (Author), Fahad Faqihi (Author), Ali B. Musa (Author), Asirvatham A. Robert (Author), Nisreen Alsherbeeni (Author), Fatehi Elzein (Author)
• Format: Book
• Published: Elsevier, 2021-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: SARS-CoV-2 is associated with a severe inflammatory response contributing to respiratory and systemic manifestations, morbidity, and mortality in patients with coronavirus disease 2019 (COVID-19). Methods: Tocilizumab (TCZ) efficacy on mortality and length of hospital stay was retrospect...